Plasma MMPs and RA-ILD. Strong association MMPs 7 & 9 with prevalent RA-ILD. Abstr#0770 #ACR23 @RheumNow https://t.co/5qWeK3lAly https://t.co/SyZY2OhcbH

Always great to see UCSD represent at #ACR23! Pregnant women with rheumatic diseases and antiphospholipid syndrome higher a HIGHER risk for acute cardiovascular events 30% of events occurred postpartum @RheumNow Abs#0722 https://t.co/CqZedfOlBC

Are anti CCP3 the new anti CCP2 antibodies? Not yet! Anti-CCP3 associated w/ diagnosis of RA in a population of patients w/ MSK symptoms But… very strong overlap between CCP2 and 3 with only 3.4% positive for CCP3 negative for CCP2 @RheumNow #ACR23 ABST 0389 https://t.co/BHRqCbqEYw

Detectable hs-cTnT at baseline was associated with future MACE HR 5.6, in the hsCRP high→low cohort with high inflammation at baseline, not vice versa. hs-cTnT may provide additional info for assessing CV risk, Weber et al, Abst#0387 https://t.co/M4zyz2tzIO #ACR23 @RheumNow https://t.co/omMgpRzBA5

Non invasive screening for pulmonary involvement in early RA Combination of PFT and Lung 🫁 US: -50% with interstitial or focal changes or pleural effusion on US -58% with abnormal DLCO Correlation w/ higher disease activity. Pathological meaning? @RheumNow ABST 0393 #ACR23 https://t.co/BBcOEgcJK2

WEAR study: adherence to wearable activity trackers in RA Something that is consistent across all wearable studies is low adherence Here under 50% for PRO + tracking In an already selected population! To implement, we need to make this better? ABSTRACT 0344 @RheumNow #ACR23 https://t.co/csVZlzABGt

Year in Review: Dr. P Seo ⭐️Does Pizza consumption favor improved dz activity in RA? If in Italy ➡️ 365 pts w/RA in Milan: 18-65 yo w/ >3 mo dz ➡️Ate 1/2 a pizza > 1x/wk w/ decr in dz activity (SDAI⬇️: -3.6) ➡️Mozzarella & olive oil showed beneficial effects #ACR23 @RheumNow https://t.co/qZTzThI39e

Towards more personalised care in rheumatoid arthritis #ACR23 @RheumNow https://t.co/roxtcX8QHI

RA as a young woman used to mean kids were only a distant thought. Japanese RA pts n=280 asked whether RA onset meant wanting fewer children & why. Confidence improving across the board over time. We want to give our RA pts choices to live their life! #ACR23 ABST0473 @RheumNow https://t.co/OHZM2J5qxS

Year in Review: Dr. P Seo Novel RA therapy on the horizon: ⭐️ABBV-3373 ➡️ Adalimumab (ADA) + GC receptor modulator vs ADA ➡️ Phase II, 48 pts, previously failed MTX ➡️ Wk 12: better DAS28-CRP, ACR20/70 🚩71% of responders stayed in remission after switch to PBO #ACR23 @RheumNow